Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
Royalty Pharma PLC (RPRX) had Days Sales in Receivables of 4.27 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$609.29M |
|
$288.22M |
|
-- |
|
$609.29M |
|
$182.13M |
|
$427.16M |
|
$17.05M |
|
$444.21M |
|
$391.73M |
|
$444.21M |
|
$444.21M |
|
$444.21M |
|
$391.73M |
|
$427.16M |
|
$436.28M |
|
431.89M |
|
559.61M |
|
$0.67 |
|
$0.67 |
|
| Balance Sheet Financials | |
$1.85B |
|
$15.76B |
|
$17.50B |
|
$19.35B |
|
$530.80M |
|
$8.57B |
|
$9.20B |
|
$9.73B |
|
$9.62B |
|
$8.70B |
|
$9.62B |
|
988.99M |
|
| Cash Flow Statement Financials | |
$1.66B |
|
$-766.38M |
|
$-886.38M |
|
$929.03M |
|
$938.94M |
|
$9.92M |
|
$164.13M |
|
$-686.38M |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.48 |
|
-- |
|
-- |
|
0.47 |
|
0.93 |
|
100.00% |
|
70.11% |
|
70.11% |
|
-- |
|
72.91% |
|
47.30% |
|
$698.63M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
21.08 |
|
|
Days Sales in Receivables |
4.27 |
4.62% |
|
5.11% |
|
2.30% |
|
2.44% |
|
$9.73 |
|
$1.25 |
|
$2.97 |
|